Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Kagamu

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|April 8, 1998
Purification of L-selectin(low) cells promotes the generation of highly potent CD4 antitumor effector T lymphocytesH Kagamu, S Shu
Archivum Immunologiae Et Therapiae Experimentalis|January 19, 2002
Cancer immunogene therapyH Yoshizawa, H Kagamu, F Gejyo
Annals of Hematology|November 18, 2019
Unexpected response of extramedullary plasmacytoma in patients with lung cancer who received nivolumabOu Yamaguchi, K Kaira, Y Nakamura, et al.
Biochemical and Biophysical Research Communications|August 15, 1994
Low oxygen enhances endothelin-1 (ET-1) production and responsiveness to ET-1 in cultured cardiac myocytesH Kagamu, T Suzuki, M Arakawa, et al.
Cellular Immunology|March 24, 1999
Critical role of CD11a (LFA-1) in therapeutic efficacy of systemically transferred antitumor effector T cellsS Mukai, H Kagamu, S Shu, et al.
Scandinavian Journal of Immunology|February 20, 2008
Appropriate timing of CD40 ligation for RNA-Pulsed DCs to induce antitumor immunityS Miura, H Kagamu, H Tanaka, et al.
Cancer Research|October 1, 1996
Isolation based on L-selectin expression of immune effector T cells derived from tumor-draining lymph nodesH Kagamu, J E Touhalisky, G E Plautz, et al.
In Vitro Cellular & Developmental Biology. Animal|February 18, 1998
Contraction and intracellular calcium-ion elevation of cultured human aortic smooth muscle cells by endothelin-1, vasoactive intestinal contractor (VIC) and the derivativesA Iwashima, M Kobayashi, K Saida, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 27, 1999
Successful adoptive immunotherapy of murine poorly immunogenic tumor with specific effector cells generated from gene-modified tumor-primed lymph node cellsH Tanaka, H Yoshizawa, Y Yamaguchi, et al.
Nihon Kyobu Shikkan Gakkai Zasshi|May 1, 1997
[Bronchiolitis obliterans and no radiographic abnormalities in a patient with rheumatoid arthritis]H Kagamu, T Hasegawa, K Kurashige, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Journal of Immunology (Baltimore, Md. : 1950)|April 8, 1998
Purification of L-selectin(low) cells promotes the generation of highly potent CD4 antitumor effector T lymphocytesH Kagamu, S Shu
Archivum Immunologiae Et Therapiae Experimentalis|January 19, 2002
Cancer immunogene therapyH Yoshizawa, H Kagamu, F Gejyo
Annals of Hematology|November 18, 2019
Unexpected response of extramedullary plasmacytoma in patients with lung cancer who received nivolumabOu Yamaguchi, K Kaira, Y Nakamura, et al.
Biochemical and Biophysical Research Communications|August 15, 1994
Low oxygen enhances endothelin-1 (ET-1) production and responsiveness to ET-1 in cultured cardiac myocytesH Kagamu, T Suzuki, M Arakawa, et al.
Cellular Immunology|March 24, 1999
Critical role of CD11a (LFA-1) in therapeutic efficacy of systemically transferred antitumor effector T cellsS Mukai, H Kagamu, S Shu, et al.
Scandinavian Journal of Immunology|February 20, 2008
Appropriate timing of CD40 ligation for RNA-Pulsed DCs to induce antitumor immunityS Miura, H Kagamu, H Tanaka, et al.
Cancer Research|October 1, 1996
Isolation based on L-selectin expression of immune effector T cells derived from tumor-draining lymph nodesH Kagamu, J E Touhalisky, G E Plautz, et al.
In Vitro Cellular & Developmental Biology. Animal|February 18, 1998
Contraction and intracellular calcium-ion elevation of cultured human aortic smooth muscle cells by endothelin-1, vasoactive intestinal contractor (VIC) and the derivativesA Iwashima, M Kobayashi, K Saida, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 27, 1999
Successful adoptive immunotherapy of murine poorly immunogenic tumor with specific effector cells generated from gene-modified tumor-primed lymph node cellsH Tanaka, H Yoshizawa, Y Yamaguchi, et al.
Nihon Kyobu Shikkan Gakkai Zasshi|May 1, 1997
[Bronchiolitis obliterans and no radiographic abnormalities in a patient with rheumatoid arthritis]H Kagamu, T Hasegawa, K Kurashige, et al.
Pageof 2